Standards Comparison

    FDA 21 CFR Part 11

    Mandatory
    1997

    FDA regulation for trustworthy electronic records and signatures

    VS

    COBIT

    Voluntary
    2019

    Global framework for enterprise IT governance and management

    Quick Verdict

    FDA 21 CFR Part 11 mandates controls for trustworthy electronic records in life sciences, while COBIT provides a voluntary framework for enterprise IT governance. Regulated firms use Part 11 for compliance; all organizations adopt COBIT to align IT with business goals.

    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11: Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    Medium
    Implementation Time
    18-24 months

    Key Features

    • Establishes equivalency of electronic records to paper records
    • Mandates secure time-stamped audit trails for integrity
    • Requires unique non-repudiable electronic signatures
    • Differentiates controls for closed and open systems
    • Enforces risk-based validation and access limitations
    IT Governance

    COBIT

    COBIT 2019 Governance and Management Objectives

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Tailors governance with 11 design factors
    • 40 objectives across 5 domains EDM-APO-BAI-DSS-MEA
    • CMMI-based capability levels 0-5 for performance
    • Goals cascade links stakeholders to IT metrics
    • Separates governance from management responsibilities

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FDA 21 CFR Part 11 Details

    What It Is

    FDA 21 CFR Part 11 is a US regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It scopes to FDA predicate rules in life sciences, applying when electronic records replace paper. Uses a risk-based approach narrowed by 2003 guidance with enforcement discretion on some elements.

    Key Components

    • **Subpart BClosed/open system controls (§11.10/§11.30) including validation, audit trails, access, operational/authority/device checks.
    • **Subpart CElectronic signatures (§11.50-11.300) for uniqueness, manifestation, linking, multi-component authentication.
    • Core principles: authenticity, integrity, non-repudiation, ALCOA+. No formal certification; compliance demonstrated via inspections.

    Why Organizations Use It

    • Mandatory for electronic reliance in regulated activities to avoid warnings/recalls.
    • Ensures data integrity, supports investigations/CAPA, enables paperless efficiency.
    • Builds regulator trust, reduces inspection risks, aids global harmonization.

    Implementation Overview

    Phased risk-based CSV: scoping, gap analysis, IQ/OQ/PQ validation, SOPs/training, supplier governance. Targets pharma/biotech/devices; all sizes. FDA enforces via inspections, no third-party audits.

    COBIT Details

    What It Is

    COBIT 2019, or Control Objectives for Information and Related Technologies, is a comprehensive framework developed by ISACA for enterprise governance and management of IT (EGIT). Its primary purpose is to help organizations create value from IT, manage risks, and optimize resources by translating stakeholder needs into actionable objectives. The approach is tailoring-focused, using design factors and a governance system workflow for customized implementation.

    Key Components

    • 40 governance and management objectives grouped into **5 domainsEDM (governance), APO (planning), BAI (delivery), DSS (operations), MEA (assurance).
    • 6 governance system principles and 3 framework principles.
    • 7 components (e.g., processes, structures, culture, skills).
    • CMMI-based performance management with capability levels 0-5; no formal certification, but capability assessments.

    Why Organizations Use It

    • Aligns IT with business strategy via goals cascade.
    • Supports compliance (e.g., SOX, GDPR) and risk management.
    • Enhances assurance, stakeholder trust, and digital transformation.
    • Provides competitive edge through optimized resources and measurability.

    Implementation Overview

    • **Phased approachassess gaps, design via toolkit, pilot objectives, train staff, monitor via MEA.
    • Suits enterprises of all sizes/industries; global applicability; requires audits but no certification.

    Key Differences

    Scope

    FDA 21 CFR Part 11
    Electronic records/signatures trustworthiness
    COBIT
    Enterprise I&T governance/management

    Industry

    FDA 21 CFR Part 11
    FDA-regulated life sciences
    COBIT
    All industries worldwide

    Nature

    FDA 21 CFR Part 11
    Mandatory US regulation
    COBIT
    Voluntary governance framework

    Testing

    FDA 21 CFR Part 11
    Risk-based system validation
    COBIT
    Capability/maturity assessments

    Penalties

    FDA 21 CFR Part 11
    Warning letters, enforcement actions
    COBIT
    No legal penalties

    Frequently Asked Questions

    Common questions about FDA 21 CFR Part 11 and COBIT

    FDA 21 CFR Part 11 FAQ

    COBIT FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages